Integra LifeSciences Holdings Co. Forecasted to Earn Q2 2023 Earnings of $0.77 Per Share (NASDAQ:IART)

Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) – Stock analysts at Zacks Research dropped their Q2 2023 earnings per share estimates for shares of Integra LifeSciences in a research report issued to clients and investors on Monday, May 8th. Zacks Research analyst R. Anand now forecasts that the life sciences company will post earnings […]

Related Keywords

Alabama ,United States ,Texas ,Integra Lifescience ,Lisa Evoli ,Integra Lifesciences ,Michaelj Mcbreen ,Integra Lifesciences Holdings Co ,Teza Capital Management ,Northcrest Asset Manangement ,Integra Lifesciences Holdings Corp ,Citigroup ,Nasdaq ,Dakota Investment Council ,Zacks Research ,Integra Lifesciences Holdings ,Get Rating ,Capital Management ,Retirement System ,Crest Asset Manangement ,Retirement Systems ,Lifesciences Holdings ,Codman Specialty Surgical ,Tissue Technologies ,Integra Lifesciences Daily ,Nasdaq Iart ,Tiart ,Medical ,45798520 ,Earnings Estimates ,